Selected research
Industry Research
Animal Prescription Drugs Industry Research Report 2026
Market perspective
The global Animal Prescription Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Animal Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Animal Prescription Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Animal Prescription Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Animal Prescription Drugs include Zoetis, Virbac, Vetoquinol, Ourofino Saude Animal, MSD Animal Health, Elanco Animal Health, Dechra, Ceva Sante Animale and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Animal Prescription Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Prescription Drugs Market by Company
Zoetis
Virbac
Vetoquinol
Ourofino Saude Animal
MSD Animal Health
Elanco Animal Health
Dechra
Ceva Sante Animale
Boehringer Ingelheim
Animalcare Group
Animal Prescription Drugs Segment by Type
Injection Type
Smear Type
Spray Type
Oral Type
Animal Prescription Drugs Segment by Application
Companion Animal
Livestock Animal
Animal Prescription Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Prescription Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Prescription Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Prescription Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal Prescription Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal Prescription Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal Prescription Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Type
- Smear Type
- Spray Type
- Oral Type
Applications
- Companion Animal
- Livestock Animal
Companies covered
- Zoetis
- Virbac
- Vetoquinol
- Ourofino Saude Animal
- MSD Animal Health
- Elanco Animal Health
- Dechra
- Ceva Sante Animale
- Boehringer Ingelheim
- Animalcare Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Animal Prescription Drugs Market Size (2021-2032)
- 2.2.2 Global Animal Prescription Drugs Sales (2021-2032)
- 2.2.3 Global Animal Prescription Drugs Market Average Price (2021-2032)
- 2.3 Animal Prescription Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection Type
- 2.3.3 Smear Type
- 2.3.4 Spray Type
- 2.3.5 Oral Type
- 2.4 Animal Prescription Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Companion Animal
- 2.4.3 Livestock Animal
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Animal Prescription Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Animal Prescription Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Animal Prescription Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Animal Prescription Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Animal Prescription Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Animal Prescription Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Animal Prescription Drugs, Product Type & Application
- 3.8 Global Manufacturers of Animal Prescription Drugs, Established Date
- 3.9 Global Animal Prescription Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Animal Prescription Drugs Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Virbac
- 4.2.1 Virbac Company Information
- 4.2.2 Virbac Business Overview
- 4.2.3 Virbac Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Virbac Animal Prescription Drugs Product Portfolio
- 4.2.5 Virbac Recent Developments
- 4.3 Vetoquinol
- 4.3.1 Vetoquinol Company Information
- 4.3.2 Vetoquinol Business Overview
- 4.3.3 Vetoquinol Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Vetoquinol Animal Prescription Drugs Product Portfolio
- 4.3.5 Vetoquinol Recent Developments
- 4.4 Ourofino Saude Animal
- 4.4.1 Ourofino Saude Animal Company Information
- 4.4.2 Ourofino Saude Animal Business Overview
- 4.4.3 Ourofino Saude Animal Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ourofino Saude Animal Animal Prescription Drugs Product Portfolio
- 4.4.5 Ourofino Saude Animal Recent Developments
- 4.5 MSD Animal Health
- 4.5.1 MSD Animal Health Company Information
- 4.5.2 MSD Animal Health Business Overview
- 4.5.3 MSD Animal Health Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MSD Animal Health Animal Prescription Drugs Product Portfolio
- 4.5.5 MSD Animal Health Recent Developments
- 4.6 Elanco Animal Health
- 4.6.1 Elanco Animal Health Company Information
- 4.6.2 Elanco Animal Health Business Overview
- 4.6.3 Elanco Animal Health Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Elanco Animal Health Animal Prescription Drugs Product Portfolio
- 4.6.5 Elanco Animal Health Recent Developments
- 4.7 Dechra
- 4.7.1 Dechra Company Information
- 4.7.2 Dechra Business Overview
- 4.7.3 Dechra Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dechra Animal Prescription Drugs Product Portfolio
- 4.7.5 Dechra Recent Developments
- 4.8 Ceva Sante Animale
- 4.8.1 Ceva Sante Animale Company Information
- 4.8.2 Ceva Sante Animale Business Overview
- 4.8.3 Ceva Sante Animale Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ceva Sante Animale Animal Prescription Drugs Product Portfolio
- 4.8.5 Ceva Sante Animale Recent Developments
- 4.9 Boehringer Ingelheim
- 4.9.1 Boehringer Ingelheim Company Information
- 4.9.2 Boehringer Ingelheim Business Overview
- 4.9.3 Boehringer Ingelheim Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boehringer Ingelheim Animal Prescription Drugs Product Portfolio
- 4.9.5 Boehringer Ingelheim Recent Developments
- 4.10 Animalcare Group
- 4.10.1 Animalcare Group Company Information
- 4.10.2 Animalcare Group Business Overview
- 4.10.3 Animalcare Group Animal Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Animalcare Group Animal Prescription Drugs Product Portfolio
- 4.10.5 Animalcare Group Recent Developments
5 Global Animal Prescription Drugs Market Scenario by Region
- 5.1 Global Animal Prescription Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Animal Prescription Drugs Sales by Region: 2021-2032
- 5.2.1 Global Animal Prescription Drugs Sales by Region: 2021-2026
- 5.2.2 Global Animal Prescription Drugs Sales by Region: 2027-2032
- 5.3 Global Animal Prescription Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Animal Prescription Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Animal Prescription Drugs Revenue by Region: 2027-2032
- 5.4 North America Animal Prescription Drugs Market Facts & Figures by Country
- 5.4.1 North America Animal Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Animal Prescription Drugs Sales by Country (2021-2032)
- 5.4.3 North America Animal Prescription Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Animal Prescription Drugs Market Facts & Figures by Country
- 5.5.1 Europe Animal Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Animal Prescription Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Animal Prescription Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Animal Prescription Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Animal Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Animal Prescription Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Animal Prescription Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Animal Prescription Drugs Market Facts & Figures by Country
- 5.7.1 South America Animal Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Animal Prescription Drugs Sales by Country (2021-2032)
- 5.7.3 South America Animal Prescription Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Animal Prescription Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Animal Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Animal Prescription Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Animal Prescription Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Animal Prescription Drugs Sales by Type (2021-2032)
- 6.1.1 Global Animal Prescription Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Animal Prescription Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Animal Prescription Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Animal Prescription Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Animal Prescription Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Animal Prescription Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Animal Prescription Drugs Sales by Application (2021-2032)
- 7.1.1 Global Animal Prescription Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Animal Prescription Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Animal Prescription Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Animal Prescription Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Animal Prescription Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Animal Prescription Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Animal Prescription Drugs Value Chain Analysis
- 8.1.1 Animal Prescription Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Animal Prescription Drugs Production Mode & Process
- 8.2 Animal Prescription Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Animal Prescription Drugs Distributors
- 8.2.3 Animal Prescription Drugs Customers
9 Global Animal Prescription Drugs Analyzing Market Dynamics
- 9.1 Animal Prescription Drugs Industry Trends
- 9.2 Animal Prescription Drugs Industry Drivers
- 9.3 Animal Prescription Drugs Industry Opportunities and Challenges
- 9.4 Animal Prescription Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst